방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| HTA(Health Technology Assessment)에서의 비용-효과 분석× | 임상 감사× | |
|---|---|---|
| 분야 | 의료경영 | 의료경영 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1996 | 1989 |
| 창시자≠ | Diane Meade Drummond, Michael Gold | UK National Health Service and healthcare quality movements |
| 유형≠ | Economic evaluation methodology | Systematic quality review methodology |
| 원전≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Institute of Medicine. (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press. DOI ↗ |
| 별칭 | CEA, Cost-Effectiveness Analysis Healthcare | Medical Audit, Healthcare Quality Audit |
| 관련 | 5 | 5 |
| 요약≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | Clinical audit is a systematic, cyclical process that measures the quality of clinical care against evidence-based standards and benchmarks, identifies gaps, and implements improvements to bring practice into alignment with current best evidence. Originating in the UK NHS, clinical audit is now a fundamental quality assurance tool in healthcare organizations worldwide. |
| ScholarGate데이터셋 ↗ |
|
|